Pfizer CEO promises to accelerate vaccine development to less than 100 days to counter the ‘high probability’ that Covid mutant mutations will make conventional shots ineffective
- Albert Bourla, CEO of Pfizer, spoke at Davos ’meaningful summit on Friday
- Bourla said they were working on speeding up the process of creating vaccines
- Vaccines against COVID-19 developed in peak time: Bourla says they need to go faster
- The Chief Executive also warned that vaccinations may not be effective in the future
The head of pharmaceutical giant Pfizer has revealed that his company is trying to accelerate vaccine development in less than 100 days, warning that there is a ‘high potential’ that future vaccines would not be effective.
New York-based Pfizer was the first company in the world to make the COVID-19 vaccine, which is currently administered worldwide.
But Albert Bourla, President, told the 2021 Davos World Economic Forum that vaccines may not be a one – day solution, in a session held Friday.
‘It’s very possible that one day it will happen,’ Bourla said, according to Business Insider.
Albert Bourla, CEO of Pfizer, spoke at Davos ’meaningful summit on Friday
His company’s vaccine against COVID-19 was the first to be approved
Bourla said Pfizer was working to accelerate vaccine research and development if that happened.
Bourla said, in preparation for future pandemics, they plan to move from recognizing the threat of the disease to getting an authorized vaccine in less than 100 days – an even shorter timeline than the target. A 300-day launch last year by Operation Warp at the Trump Administration.
COVID-19 vaccines have been developed at a faster pace, as a result of technological advances, large funding and public willingness to participate in trials.
Bourla was one of four speakers at a panel talking about the need for collaboration between business and governments to address future threats to human health.
Norway ‘s foreign minister, Ine Eriksen Soreide; head of the World Health Organization, Tedros Adhanom Ghebreyesus; German health minister Jens Spahn; and Richard Hatchett, Head of the Consortium for Epidemic Preparation and Innovation.
Bourla warned that the world could not be complacent about vaccines
Bourla said Pfizer was working to speed up the vaccine development process
Hatchett stressed the need to be ready for recycling, according to the site.
‘Governments need to recognize that emerging infectious diseases and pandemic strains are a lasting threat to our society,’ said Hatchett, former director of the Biomedical Research and Development Authority.
‘They are assets that emerge in the way we live. ‘
Hatchett said governments need to invest in preparing for future pandemics, warning that future pandemics could be even more deadly.